Home - Products - Others - Other Targets - 15,26-Dihydroxylanosta-7,9(11),24-trien-3-one

15,26-Dihydroxylanosta-7,9(11),24-trien-3-one

CAS No. 420781-85-7

15,26-Dihydroxylanosta-7,9(11),24-trien-3-one( —— )

Catalog No. M32555 CAS No. 420781-85-7

The fruit body of Ganoderma lucidum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 664 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    15,26-Dihydroxylanosta-7,9(11),24-trien-3-one
  • Note
    Research use only, not for human use.
  • Brief Description
    The fruit body of Ganoderma lucidum.
  • Description
    The fruit body of Ganoderma lucidum.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    420781-85-7
  • Formula Weight
    454.7
  • Molecular Formula
    C30H46O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Frovocimab

    Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody to Subtilisin/Kexin Protein Converting Enzyme Type 9 (PCSK9) that binds to the catalytic domain of PCSK9 and lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia.Frovocimab is used in the study of hypercholesterolemia.

  • Eupteleasaponin I

    Eupteleasaponin I is a natural product from Euptelea polyandra Sieb. et Zucc.

  • IRG1-IN-1

    IRG1-IN-1, an itaconic acid derivative, inhibits Immune Response Gene 1 (IRG1) activity and is suitable for cancer, inflammation, and autoimmune disease research.